Goldline Pharmaceutical Ltd (NSE: GLPL), ISIN INE1CLW01015 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
GLPL last traded at ₹40.00 (+2.83%), with a 52-week range of ₹33.00 to ₹60.00 (as of 25 Aug 2026).
EquiSense Score (ECS): 72/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.